Sharma, Gaurav

Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients

McNeely, J., Wu, L.-T., Subramaniam, G., Sharma, G., Cathers, L. A., Svikis, D., Sleiter, L., Russell, L., Nordeck, C., Sharma, A., et al. (2016) · Annals of Internal Medicine

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 320

Bupropion and naltrexone in methamphetamine use disorder

Trivedi, M. H., Walker, R., Ling, W., dela Cruz, A., Sharma, G., Carmody, T., Ghitza, U. E., Wahle, A., Kim, M., Shores-Wilson, K., et al. (2021) · New England Journal of Medicine

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 281

Brief Intervention for Patients With Problematic Drug Use Presenting in Emergency Departments: A Randomized Clinical Trial

Bogenschutz, M. P., Donovan, D. M., Mandler, R. N., Perl, H. I., Forcehimes, A. A., Crandall, C., Lindblad, R., Oden, N. L., Sharma, G., Metsch, L., et al. (2014) · JAMA Internal Medicine

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 118

PPT1 inhibition enhances the antitumor activity of anti–PD-1 antibody in melanoma

Sharma, G., Ojha, R., Noguera-Ortega, E., Rebecca, V. W., Attanasio, J., Liu, S., Piao, S., Lee, J. J., Nicastri, M. C., Harper, S. L., et al. (2020) · JCI Insight

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 80